BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10572948)

  • 1. Interactions between neutrophil gelatinase-associated lipocalin and natural lipophilic ligands.
    Bratt T; Ohlson S; Borregaard N
    Biochim Biophys Acta; 1999 Oct; 1472(1-2):262-9. PubMed ID: 10572948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4.
    Dewald B; Baggiolini M
    Biochem Biophys Res Commun; 1985 Apr; 128(1):297-304. PubMed ID: 2985075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL).
    Strong RK; Bratt T; Cowland JB; Borregaard N; Wiberg FC; Ewald AJ
    Acta Crystallogr D Biol Crystallogr; 1998 Jan; 54(Pt 1):93-5. PubMed ID: 9761822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression.
    Friedl A; Stoesz SP; Buckley P; Gould MN
    Histochem J; 1999 Jul; 31(7):433-41. PubMed ID: 10475571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic peptide down-regulation of calcium mobilization induced by platelet-activating factor and by leukotriene B4 in human neutrophils is uncovered by protein phosphatase inhibitors.
    Montero M; Garcia-Sancho J; Alverez J
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):559-66. PubMed ID: 7980418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin.
    Goetz DH; Willie ST; Armen RS; Bratt T; Borregaard N; Strong RK
    Biochemistry; 2000 Feb; 39(8):1935-41. PubMed ID: 10684642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin.
    Rudd PM; Mattu TS; Masure S; Bratt T; Van den Steen PE; Wormald MR; Küster B; Harvey DJ; Borregaard N; Van Damme J; Dwek RA; Opdenakker G
    Biochemistry; 1999 Oct; 38(42):13937-50. PubMed ID: 10529240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse.
    Kjeldsen L; Cowland JB; Borregaard N
    Biochim Biophys Acta; 2000 Oct; 1482(1-2):272-83. PubMed ID: 11058768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP
    J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA; Wooten RE
    Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists.
    Palmantier R; Borgeat P
    Br J Pharmacol; 1991 Aug; 103(4):1909-16. PubMed ID: 1655146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.
    Kjeldsen L; Bainton DF; Sengeløv H; Borregaard N
    Blood; 1994 Feb; 83(3):799-807. PubMed ID: 8298140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
    Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G
    Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP; McColl SR; Braquet P; Borgeat P
    Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.
    Yan L; Borregaard N; Kjeldsen L; Moses MA
    J Biol Chem; 2001 Oct; 276(40):37258-65. PubMed ID: 11486009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
    Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
    J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans.
    Cowland JB; Borregaard N
    Genomics; 1997 Oct; 45(1):17-23. PubMed ID: 9339356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
    Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L
    Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-HODE inhibits the intracellular calcium increase of activated human polymorphonuclear cells.
    van de Velde MJ; Engels F; Henricks PA; Nijkamp FP
    J Leukoc Biol; 1994 Aug; 56(2):200-2. PubMed ID: 8071595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate.
    Tool AT; Verhoeven AJ
    Arzneimittelforschung; 1995 Oct; 45(10):1110-4. PubMed ID: 8595070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.